Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia

Published: 27 August 2020| Version 1 | DOI: 10.17632/chxvtg2fnn.1
Contributor:
Caslin Gilroy

Description

All raw data associated with the article entitled "Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia." Separated into individual spreadsheets.

Files